Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation
Authors:
- Jakob R. PasswegJPJakob R. Passweg
- Ulrike KoehlUKUlrike Koehl
- Lutz UharekLULutz Uharek
- Sandrine Meyer-MonardSMSandrine Meyer-Monard
- André TichelliATAndré Tichelli
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 19 (4) , 811-824
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Unravelling natural killer cell function: triggering and inhibitory human NK receptorsThe EMBO Journal, 2003
- Natural killer cells and viral infectionsCurrent Opinion in Immunology, 2003
- Alloreactive killer cells: hindrance and help for haematopoietic transplantsNature Reviews Immunology, 2003
- New aspects of natural-killer-cell surveillance and therapy of cancerNature Reviews Cancer, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive ImmunityAnnual Review of Immunology, 2002
- Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cellsMolecular Immunology, 2002
- What is a natural killer cell?Nature Immunology, 2002
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- Biology and clinical relevance of human natural killer cellsBlood, 1990